We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Drug Cuts Risk of Breast Cancer With Fewer Side Effects
Eli Lilly Drug Cuts Risk of Breast Cancer With Fewer Side Effects
April 21, 2006
An osteoporosis drug cuts the risk of breast cancer in postmenopausal women, with fewer side effects than a widely used existing drug, according to a report issued April 17 by the National Cancer Institute.